<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Loss of a whole chromosome 5 or a deletion of the long arm, del(5q), is a recurring abnormality in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (MDSs) and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>To identify a <z:hpo ids='HP_0001909'>leukemia</z:hpo>-related gene on chromosome 5, we previously delineated a 970-kb segment of 5q31 that is deleted in <z:hpo ids='HP_0000001'>all</z:hpo> patients examined, and prepared a transcript map of this region </plain></SENT>
<SENT sid="2" pm="."><plain>EGR1 is a candidate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene within the commonly deleted segment of 5q, and encodes a zinc finger transcription factor </plain></SENT>
<SENT sid="3" pm="."><plain>To test the hypothesis that loss of function of Egr1 is an initiating event in the pathogenesis of <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e>, Egr1-deficient mice were treated with a potent DNA <z:chebi fb="0" ids="22333">alkylating agent</z:chebi>, N-<z:chebi fb="0" ids="23995">ethyl-nitrosourea</z:chebi> (<z:chebi fb="0" ids="23995">ENU</z:chebi>), to induce secondary cooperating mutations </plain></SENT>
<SENT sid="4" pm="."><plain>Egr1(+/-) and Egr1(-/-) mice treated with <z:chebi fb="0" ids="23995">ENU</z:chebi> developed immature T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (CD4(+), CD8(+)) or a <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>) at increased rates and with shorter latencies than that of <z:mp ids='MP_0002169'>wild-type</z:mp> littermates </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> was characterized by an elevated white blood cell count, <z:hpo ids='HP_0001903'>anemia</z:hpo>, and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> with <z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Biallelic mutations of Egr1 were not observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> in Egr1(+/-) mice </plain></SENT>
<SENT sid="7" pm="."><plain>Our data suggest that haploinsufficiency for Egr1 plays a role in murine <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e>, and in the development of <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> characterized by abnormalities of chromosome 5 </plain></SENT>
</text></document>